Literature DB >> 22076306

Molecular biology of oncogenic inflammatory processes. I. Non-oncogenic and oncogenic pathogens, intrinsic inflammatory reactions without pathogens, and microRNA/DNA interactions (Review).

Joseph G Sinkovics1.   

Abstract

In some inflammasomes tumor cells are generated. The internal environment of the inflammasome is conducive to the induction of malignant transformation. Epigenetic changes initiate this process. The subverted stromal connective tissue cells act to promote and sustain the process of malignant trans-formation. In its early stages, the premalignant cells depend on paracrine circuitries for the reception of growth factors. The ligands are derived from the connective tissue, and the receptors are expressed on the recipient premalignant cells. The initial events are not a direct attack on the proto-oncogenes, and thus it may be entirely reversible. Epigenetic processes of hypermethylation of the genes at the promoters of tumor suppressor genes (to silence them), and deacetylation of the histones aimed at the promoters of proto-oncogenes (to activate them) are on-going. A large number of short RNA sequences (interfering, micro-, short hairpin, non-coding RNAs) silence tumor suppressor genes, by neutralizing their mRNAs. In a serial sequence oncogenes undergo amplifications, point-mutations, translocations and fusions. In its earliest stage, the process is reversible by demethylation of the silenced suppressor gene promoters (to reactivate them), or re-acetylation of the histones of the oncogene promoters, thus de-activating them. The external administration of histone deacetylase inhibitors usually leads to the restoration of histone acetylation. In time, the uncorrected processes solidify into constitutive and irreversible gene mutations. Some of the pathogens inducing inflammations with consquential malignant transformation contain oncogenic gene sequences (papilloma viruses, Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, hepatitis B and C viruses, Merkel cell polyoma virus, Helicobacter pylori, enterotoxigenic Bacteroides fragilis). These induced malignancies may be multifocal. Other pathogens are devoid of any known oncogenic genomic sequences (mycoplasma vav-carcinogenesis, chlamydia MALT-lymphoma genesis). In these cases the host's inflammatory reactions induce the malignant transformation in serial sequences of gene alterations initiated by hypoxia and reactive oxygen and nitrogen species generation. Carcinogenic intrinsic inflammatory processes endogenously initiated without a pathogen are recognized. Chronic inflammatory processes signal the RNA/DNA complex. In response, the DNA may revert into its ancient primordial 'immortal' format, which the clinics recognize as 'oncogenesis'. The DNA remains the ultimate master of bioengineering in order to sustain life. A discussion on the most versatile and resistant primordial RNA/DNA complex and the pre-, proto-, and unicellular world in which they co-existed is included.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076306     DOI: 10.3892/ijo.2011.1248

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  11 in total

1.  STAT1 regulates MD-2 expression in monocytes of sepsis via miR-30a.

Authors:  Yanhong Wang; Tiehua Li; Benquan Wu; Hui Liu; Jinmei Luo; Dingyun Feng; Yunfeng Shi
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

Review 2.  The cell survival pathways of the primordial RNA-DNA complex remain conserved in the extant genomes and may function as proto-oncogenes.

Authors:  J G Sinkovics
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

3.  Up-regulation of Ago2 expression in gastric carcinoma.

Authors:  Jin Zhang; Xiang-shan Fan; Cai-xia Wang; Biao Liu; Qin Li; Xiao-jun Zhou
Journal:  Med Oncol       Date:  2013-06-18       Impact factor: 3.064

Review 4.  Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control.

Authors:  Russell L Blaylock
Journal:  Surg Neurol Int       Date:  2015-05-29

Review 5.  MicroRNA Regulation of Epithelial to Mesenchymal Transition.

Authors:  Mohammed L Abba; Nitin Patil; Jörg Hendrik Leupold; Heike Allgayer
Journal:  J Clin Med       Date:  2016-01-14       Impact factor: 4.241

6.  Potential malignant transformation in the gastric mucosa of immunodeficient mice with persistent Mycoplasma penetrans infection.

Authors:  Shuyan Cao; Dandan Shen; Yadong Wang; Linxi Li; Liping Zhou; Yuxue Wang
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

7.  Detecting the Diversity of Mycoplasma and Ureaplasma Endosymbionts Hosted by Trichomonas vaginalis Isolates.

Authors:  Anastasios Ioannidis; Panagiota Papaioannou; Emmanouil Magiorkinis; Maria Magana; Vasiliki Ioannidou; Konstantina Tzanetou; Angeliki R Burriel; Maria Tsironi; Stylianos Chatzipanagiotou
Journal:  Front Microbiol       Date:  2017-06-28       Impact factor: 5.640

Review 8.  The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review).

Authors:  Joseph G Sinkovics
Journal:  Int J Oncol       Date:  2015-07-23       Impact factor: 5.650

Review 9.  Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.

Authors:  Arun George Paul; Bala Chandran; Neelam Sharma-Walia
Journal:  Transl Res       Date:  2013-04-06       Impact factor: 7.012

Review 10.  The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas.

Authors:  Pinelopi I Artemaki; Petros A Letsos; Ioanna C Zoupa; Katerina Katsaraki; Paraskevi Karousi; Sotirios G Papageorgiou; Vasiliki Pappa; Andreas Scorilas; Christos K Kontos
Journal:  Biomedicines       Date:  2021-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.